StreetInsider.com News Articles

Form PRE 14A KALA BIO, Inc. For: Sep 11

Fri, 11 Sep 2026 16:57:00 -0400

si-local-file:///var/storage/secattach/20260911/27053523.html

Form 8-K KALA BIO, Inc. For: Sep 03

Thu, 10 Sep 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260910/27049481.html

Kala Bio signs exclusive U.S. deal to distribute Virotek eye genetic tests

Thu, 03 Sep 2026 08:33:02 -0400

Kala Bio, Inc. (Nasdaq: KALA) and Virotek Inc. have finalized an exclusive distribution and reseller agreement under which Kala will serve as the sole U.S. distributor of Virotek's ophthalmology genomic testing and screening program, according to a press release from the companies.

The agreement, which took effect September 4, 2026, grants Kala the right to market, promote, distribute, and resell Virotek's ophthalmology genetic testing program across the United States for an initial one-year term. Continued exclusivity depends on Kala meeting agreed commercial milestones. The agreement follows a non-binding letter of intent announced September 1, 2026.

Under the terms, Virotek retains responsibility for

Kala Bio signs exclusive U.S. deal to distribute Virotek eye genetic tests

Thu, 03 Sep 2026 08:33:02 -0400

Under the terms, Virotek retains responsibility for

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Thu, 03 Sep 2026 08:30:00 -0400

Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program

ARLINGTON, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek") today announced that they have finalized a definitive exclusive distribution and reseller agreement (the "Agreement") and related quality, brand, and data protection agreements. Under the Agreement, Kala will be the exclusive distributor and reseller in the United States for an initial one-year term, with continued exclusivity contingent on Kala achieving agreed commercial milestones for Virotek's ophthalmology genetic testing and screening program. The Agreement follows the

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Thu, 03 Sep 2026 08:30:00 -0400

Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Tue, 01 Sep 2026 07:45:00 -0400

ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the "LOI") outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the exclusive distributor and reseller in the United States of Virotek's genetic testing and screening program for ophthalmological indications.

Under the framework outlined in the LOI, Kala would market, promote, and distribute Virotek's ophthalmology genetic testing and screening program to eye

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Tue, 01 Sep 2026 07:45:00 -0400

Under the framework outlined in the LOI, Kala would market, promote, and distribute Virotek's ophthalmology genetic testing and screening program to eye

Form 8-K KALA BIO, Inc. For: Aug 27

Fri, 28 Aug 2026 06:45:00 -0400

si-local-file:///var/storage/secattach/20260828/26992863.html

Form 8-K KALA BIO, Inc. For: Aug 27

Fri, 28 Aug 2026 06:45:00 -0400

si-local-file:///var/storage/secattach/20260828/26992863.html

Form 10-Q KALA BIO, Inc. For: Jun 30

Wed, 19 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260819/26950295.html

Form 10-Q KALA BIO, Inc. For: Jun 30

Wed, 19 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260819/26950295.html

Form NT 10-Q KALA BIO, Inc. For: Jun 30

Fri, 14 Aug 2026 10:14:00 -0400

si-local-file:///var/storage/secattach/20260814/26926230.html

Form NT 10-Q KALA BIO, Inc. For: Jun 30

Fri, 14 Aug 2026 10:14:00 -0400

si-local-file:///var/storage/secattach/20260814/26926230.html

Form 8-K KALA BIO, Inc. For: Jul 22

Thu, 23 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260723/26803763.html

Form 8-K KALA BIO, Inc. For: Jul 22

Thu, 23 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260723/26803763.html

Form 424B5 KALA BIO, Inc.

Wed, 22 Jul 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260722/26802640.html

Form 424B5 KALA BIO, Inc.

Wed, 22 Jul 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260722/26802640.html

Form SCHEDULE 13D/A KALA BIO, Inc. Filed by: Lazar David E.

Thu, 02 Jul 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260702/26729710.html

Form SCHEDULE 13D/A KALA BIO, Inc. Filed by: Lazar David E.

Thu, 02 Jul 2026 17:37:00 -0400

si-local-file:///var/storage/secattach/20260702/26729710.html

Form EFFECT KALA BIO, Inc.

Fri, 26 Jun 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260626/26694573.html

Form EFFECT KALA BIO, Inc.

Fri, 26 Jun 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260626/26694573.html

Form S-3/A KALA BIO, Inc.

Fri, 12 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26640693.html

Form S-3/A KALA BIO, Inc.

Fri, 12 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26640693.html

Form SCHEDULE 13G/A KALA BIO, Inc. Filed by: BAKER BROS. ADVISORS LP

Fri, 15 May 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260515/26506086.html